Measures vanillylmandelic acid (VMA), a breakdown product of adrenaline and noradrenaline, in a 24-hour urine collection.
Used when evaluating suspected catecholamine-producing tumours (for example neuroblastoma or pheochromocytoma), often alongside other catecholamine/metanephrine tests.